Education and Experience

Education
Work history
Clinical Trial Experience
Research history by year
Research expertise

Investigator Education
University of Minnesota, College 1972 B.A. Chemistry
University of Minnesota, Medical School 1981 M.D. Medicine
University of Minnesota, School of Public Health 1983 M.P.H. Epidemiology
Beth Israel Medical Center, Manhattan, NY 1982 Internship
Beth Israel Medical Center, Manhattan, NY 1985 Residency
Mt. Sinai, Preventive and Community Medicine 1985 Residency

top

Work
Physician, 175 Main Street, Mt. Kisco 1987 - Present
Attending, Northern Westchester Hospital 1987- Present
Principal investigator, clinical trials, Mt. Kisco 1990 - Present
Assistant Professor of Medicine, Geriatric Department 1985 - 1987
Geriatrician, Veterans Hospital, Montrose 1985 - 1987
Director, Dementia Unit 1985-1987
Consulting Geriatrician, Coller Memorial Hospital 1985-1987
Physician, Cancer Detection Center 1981-1982
Teaching Assistant, Physics Department 1973-1975

top

Clinical trial Expertise
Glaxo 1988 Lyme disease
Ciba-Geigy 1988   Hypertension  
Eli Lilly 1988 Hypertension
Squibb 1988-1989 Acute bronchitis
G.D. Searle 1988-1989 Generalized anxiety
Eli Lilly 1988-1989   Analgesic (phase I, II)
UpJohn 1989 Streptococcal pharyngitis Uncomplicated urinary tract infection Wound and soft tissue infection  
LymeProject 1997-2000   Lyme Disease Surveillance Database
Pfizer 2002-3 Gemini study Clinical Utility study for Cholesterol and Hypertension Phase IIIb Open labeled, multicenter trial  
Columbia 2001-present Subinvestigator NIH sponsored trial - Columbia
LymeProject 1997-present   Lyme Disease Retreatment Study
LymeProject   2003-present   Validation of Lyme treatment (VOLT)
Merck 2003 Migraine Therapy Evaluation Protocol Muli-center, open-label, crossover study comparing Maxalt with usual care oral migraine medication
Genzyme 2004 REACH Program
An International Prospective Observational Observational Registry in Subjects at Risk Of atherothrombotic Events
Watson 2004 MATRIX Trial
Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin TDS

top

Research history by year

 
1992 1993 1994 1996 1998 1999 2000 2002 2003 2004 2005    

 

1992

Cameron DJ. Borrelia burgdorferi in the central nervous system. JAMA 1992;268: 872 (letter).

Cameron DJ. Cognitive function in late Lyme borreliosis. Arch Neurol 1992;49:1011 (letter).

Cameron DJ, Malara VP. Successful retreatment of Lyme disease. Presented at Fifth International Conference on Lyme Borreliosis; May 30-June 2, 1992: Arlington, VA.

Malara VP, Cameron DJ. Outcome of oral antibiotic treatment of Lyme disease in a community setting. Presented at the Fifth International Conference on Lyme Borreliosis; May 30,-June 2, 1992; Arlington, VA.

1993

Cameron DJ. Effectiveness of early Lyme disease treatment. Am J Med 1993;94:553 (letter).

1994

Cameron DJ., Malara VP. O'Dell C, Schreck C. Age Factor in Lyme Disease. Presented at the Sixth International Conference on Lyme Borreliosis, June 19-June 24, 1994. Bologna Italy.

Brian A. Fallon, MD, MPH, Hector Bird, MD, Christina Hoven, DrPH, Daniel Cameron, MD, MPH, Michael R. Liebowitz, MD, and David Shaffer, MD. Psychiatric aspects of Lyme disease in children and adolescents: A community epidemiologic study in Westchester, New York. Journal of Spirochetal and Tick-Borne Diseases. Vol. 1, No. 4, 1994. pp. 98-100.

Malara VP, Cameron DJ. Depressive Symptomalogy in Lyme Disease. Presented at the Sixth International Conference on Lyme Borreliosis, June 19-June 24, 1994. Bologna Italy.

Cameron DJ., Malara VP., Geriatric Lyme Disease. Presented at the Lyme Disease Foundation International Conference on Lyme Disease, May 19-May 23, 1994, Stamford, Connecticut.

1996

Cameron DJ., Malara VP. Clinical features of IgM Western Blot Lyme Borreliosis. Presented at the Seventh International Conference on Lyme Borreliosis, June 16-June 21, 1996. San Francisco, USA.

Malara VP, Cameron DJ. Non-confirmed ELISA testing for Lyme Disease: Bayes' theorum consideration. Presented at the Seventh International Conference on Lyme Borreliosis, June 16-June 21, 1996 San Francisco, USA

Cameron DJ., Malara VP., Treatment denials for Lyme Disease by managed care. Presented at the Seventh International Conference on Lyme Borreliosis, June 16-June 21, 1996. San Francisco, USA.

1998

Cameron DJ. Guidelines for the Diagnosis and Management of Chronic Lyme Disease. Presented at the Lyme Disease Foundation International Conference on Lyme Disease, April 21-April 23, 1998, New York, New York.

Cameron DJ. First Sentinel Health Site for Monitoring Lyme Disease - Monitoring Lyme Disease in the community. Presented at the Lyme Disease Foundation International Conference on Lyme Disease, April 19-April 21, 1998, New York, New York.

Cameron DJ. Monitoring Lyme Disease in the Community - First Sentinel Health Site. In Abstracts of the 12 Annual International Scientific Conference on Lyme Disease and Other Spirochetal and Tick-Borne Disorders. Manhattan, New York, 1998.

1999

Cameron DJ. First Sentinel Health Site for Lyme disease - a prospective cohort study. Proceedings of the 8th International Conference of Lyme Borreliosis. Germany, 1999.

Cameron DJ. Successful treatment of Lyme diseases relapses. Proceedings of the 8th International Conference on Lyme Borreliosis. Germany, 1999.

Cameron DJ. Failure of the Western Blot as a Confirmatory Test for Lyme Disease. Proceedings of the 8th International Conference on Lyme Borreliosis. Germany, 1999.

2000

Cameron DJ. Insensitivity of the IgG Western Blot and CDC surveillance case definition - impact on clinical trials. In Abstracts of the 13th Annual International Scientific Conference on Lyme Disease and Other Spirochetal & Tick-Borne Disorders. Farmington, Connecticut, 2000.

2002

Cameron DJ, Gaito A, Harris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey CE, Horowitz R, Phillips S, Merr-Sherrer L, Raxlen B, Sherr V, Smith H, Smith P, Stricker R. Primary changes in ILADS Evidence-Based Practice Treatment Guidelines. Submitted, International Conference on Lyme Borreliosis. Manhattan, New York, USA, 2002.

Cameron DJ, Gaito A, Harris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey CE, Horowitz R, Phillips S, Merr-Sherrer L, Raxlen B, Sherr V, Smith H, Smith P, Stricker R. Lyme Disease International Surveillance Project (LDISP). Submitted, International Conference on Lyme Borreliosis. Manhattan, New York, USA, 2002.

Cameron DJ. Validation of Lyme Disease Practice Treatment Guidelines Submitted, International Conference on Lyme Borreliosis. Manhattan, New York, USA, 2002.

Cameron DJ. Selection Bias in Clinical Trials of Lyme Disease Practice Treatment Guidelines Submitted, International Conference on Lyme Borreliosis. Manhattan, New York, USA, 2002.

Cameron DJ. The Consequence of Underdiagnosing and Undertreating Lyme Disease: The Lyme Disease Surveillance Database Study Practice Treatment Guidelines Submitted, International Conference on Lyme Borreliosis. Manhattan, New York, USA, 2002.

Cameron DJ. Feasibility of Randomized Double-Blind Placebo-Controlled Clinical Trials in Lyme Disease: Lyme Disease Retreatment Study. Practice Treatment Guidelines Submitted, International Conference on Lyme Borreliosis. Manhattan, New York, USA, 2002.

Cameron DJ. Integrating Intramuscular Benzathine Penicillin into the Treatment of Chronic Lyme Disease Submitted, International Conference on Lyme Borreliosis. Manhattan, New York, USA, 2002.

2003

Cameron DJ. VOLT – Validation of Lyme treatment. Presented to the International Lyme Disease and Associated Disorders Society (ILADS). Philadelphia, Pennyslvania, 2003.

2004

Cameron DJ, Gaito A, Harris N. et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti-infect. Ther. 2(1), 2004.

Cameron DJ. Timely treatment POEM - Patient Oriented Medicine that Matters. International Lyme and Associated Diseases Society, Rye, New York October 2004.

2005

Cameron DJ. Lyme disease Clinical Trial – Validation of ILADS Treatment Guidelines, International Lyme and Associated Diseases Annual Scientific Meeting. Philadelphia, 2005.

Cameron DJ. Lyme disease Clinical Trial – Quality of Life, Lyme Disease Association’s 6th Annual Lyme Disease Conference, Philadlphia, 2005.


top

Clinical Trial Experience

The academic and clinical experience of the principal investigator for the Lyme Disease Practice and Research is evident. His capabilities and commitment to serve as a mentor include his teaching capacity as assistant professor Medicine in Geriatrics at the New York College of Medicine. His initial master's defense in epidemiology, publications in delirium and dementia, and 12 year history of scientific presentations at Lyme disease scientific conferences are evidence of his commitment to an ongoing high quality patient-oriented research. The ongoing research contributions sponsored by the Lyme Disease Practice and Research demonstrate the evidence of monetary support for patient-oriented research.

Dr. Cameron's previous experience as an Assistant Professor and current teacher for physicians, nurse practitioners, and physician assistants demonstrates an ongoing mentor role. The 8-year series of oral and poster presentations demonstrates the ongoing commitment as a leader in patient-oriented research. The Lyme Disease Practice and Research director has provided leadership for the scientific program and have final responsibility for the scientific, administrative, and operational aspects of the project. The Director is responsible for overall coordination and for development of the Lyme Disease Practice and Research as a unique national resource.

Dr. Cameron remains active in the practice of medicine and admits patients to Northern Westchester Hospital Center. He has published and presented more than 40 scientific papers. top